nifedipine has been researched along with 11-cis-retinal in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maeda, A; Maeda, T; Maruyama, I; Nakazawa, M; Ogawa, K; Ohguro, H; Takano, Y | 1 |
| Chidlow, G; Melena, J; Osborne, NN; Schmidt, KG; Wood, JP | 1 |
| Ohguro, H | 1 |
| Ishii, K; Mori, A; Nakahara, T; Sakamoto, K | 1 |
| Chimerel, C; Gribble, FM; Murison, K; Reimann, F; Riccio, C | 1 |
2 review(s) available for nifedipine and 11-cis-retinal
| Article | Year |
|---|---|
[New drug therapy for retinal degeneration].
Topics: Animals; Calcium Channel Blockers; Dark Adaptation; Disease Models, Animal; Humans; Mice; Mutation; Nifedipine; Phosphorylation; Rats; Retinitis Pigmentosa; Rhodopsin | 2008 |
[Cause of retinitis pigmentosa and new therapeutics under development].
Topics: Animals; c-Mer Tyrosine Kinase; Carrier Proteins; cis-trans-Isomerases; Cyclic Nucleotide Phosphodiesterases, Type 6; Disease Models, Animal; Drug Design; Eye Proteins; Genetic Therapy; Humans; Intercellular Signaling Peptides and Proteins; Intermediate Filament Proteins; Membrane Glycoproteins; Molecular Targeted Therapy; Mutation; Nerve Tissue Proteins; Nifedipine; Peripherins; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Retinitis Pigmentosa; Rhodopsin; Vitamin A | 2011 |
3 other study(ies) available for nifedipine and 11-cis-retinal
| Article | Year |
|---|---|
Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
Topics: Animals; Antibodies; Antigens, Neoplasm; Calcium Channel Blockers; Calcium-Binding Proteins; Dark Adaptation; Electroretinography; Eye Proteins; Hippocalcin; Injections; Injections, Intraperitoneal; Light; Lipoproteins; Nerve Tissue Proteins; Nifedipine; Paraneoplastic Syndromes; Phosphorylation; Photoreceptor Cells, Vertebrate; Rats; Rats, Inbred BN; Rats, Inbred Lew; Recoverin; Retinal Diseases; Rhodopsin; Vitreous Body | 2001 |
Alpha-lipoic acid protects the retina against ischemia-reperfusion.
Topics: Anesthetics, Local; Animals; Antioxidants; Binding, Competitive; Brain-Derived Neurotrophic Factor; Calcium; Calcium Channel Blockers; Cells, Cultured; Ciliary Neurotrophic Factor; Diltiazem; Dizocilpine Maleate; DNA Primers; Dose-Response Relationship, Drug; Drug Interactions; Electroretinography; Fibroblast Growth Factors; Glial Fibrillary Acidic Protein; Glyceraldehyde-3-Phosphate Dehydrogenases; N-Methylaspartate; Nifedipine; Rats; Reperfusion Injury; Retinal Diseases; Reverse Transcriptase Polymerase Chain Reaction; Rhodopsin; RNA, Messenger; Sodium; Tetrodotoxin; Thioctic Acid; Thy-1 Antigens; Veratridine | 2002 |
Optogenetic Analysis of Depolarization-Dependent Glucagonlike Peptide-1 Release.
Topics: 1-Methyl-3-isobutylxanthine; Action Potentials; Animals; Calcium; Calcium Channel Blockers; Colforsin; Enteroendocrine Cells; Glucagon-Like Peptide 1; Membrane Potentials; Mice; Nifedipine; omega-Conotoxin GVIA; Optogenetics; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Rhodopsin; Sodium Channel Blockers; Tetrodotoxin; Vasodilator Agents | 2017 |